Page 18 - Synapse Life Sciences Consortium
P. 18

ToeFX: ‘Big

        Welcome mat’ in
        Hamilton

        A Hamilton company is battling the
        most pervasive and stubborn infection
        in the world – onychomycosis or toenail
        fungus.
        ToeFX uses a non-invasive and non-toxic
        light-based (photodisinfection) therapy
        to treat toenail fungus in clinical
        settings. Its system is fully approved
        in Canada and found in more than
        60 clinics. The hope is to secure FDA
        approval in 2022.
        ToeFX has aspirations to serve a global
        market, said Monika Yazdanian, CEO
        and Co-Founder of ToeFX.

        “There is a stigma to this infection
        and people hide it. One woman in our
        clinical trial has hid it from her husband
        for five years. That takes a psychological
        toll.”

        The company has benefitted from the       Hamilton’s Future:
        resources and guidance at McMaster        Reaching the Next
        and its incubator The Forge, as well as
        Innovation Factory. ToeFX won the 2021    Level of Success
        Synapse Life Sciences Competition
        and that provided great exposure
        and credibility to the company, says      Hamilton’s role as a centre for life sciences
        Yazdanian.                                innovation and commercialization in Southern ontario
                                                  will be strengthened exponentially with a massive
        “The prize money is very significant for a   build-out of the mcmaster innovation Park.
        start-up. It’s the help that you need. We
        are using it to advance our IT strategy   leveraging Hamilton’s research and innovation
        and regulatory work.”                     ecosystem, anchored by mcmaster University. it is
                                                  positioned to be ontario’s premier life sciences hub,
        ToeFX was also named among the 2021       connecting industry to applied research capabilities –
        recipients of the Ontario Bioscience      bringing local innovation to a global audience.
        Innovation Organization’s Capital Access
        Advisory Program.                         Upon completion the 58-acre miP will have a
                                                  staggering 3.5 million square feet of space, with
        “Hamilton brings it all together. And     1.3 million square feet dedicated to a life Sciences
        there is a great deal of goodwill here.   innovation megahub – a hub that will include wet
        This is a very friendly city and people   labs that will lead discovery, provide start-up spaces
        want to do what they can to help you.     to develop prototype and test products, along
        They are rooting for you,” said Yazdanian.  with early-stage production facilities and full-scale
                                                  biomanufacturing.
        “The infrastructure is here in Hamilton.
        It’s a big city but there is a lot of room.   “the Park is ontario’s fastest-growing life sciences
        A big welcome mat is out here.”           hub and the heart of Hamilton’s potential to be an
                                                  epicentre in the field,” says Karen Mossman, Vice-
                                                  President, research at mcmaster and chair of miP.

    18
   13   14   15   16   17   18   19   20   21   22   23